Skip to main content
Top

International Journal of Hematology

Issue 3/2014

Including PIH Articles on Peripheral T cell lymphoma

Content (20 Articles)

Images in Hematology

Refractory acute monoblastic leukaemia with low hypodiploidy

Su Han Lum, Tong Foh Chin, Kee Hie Lau, Tsiao Yi Yap, Revathi Rajagopal, Hany Ariffin

Progress in Hematology

Molecular genetics of peripheral T-cell lymphomas

Pier Paolo Piccaluga, Valentina Tabanelli, Stefano A. Pileri

Progress in Hematology

Peripheral T cell lymphoma in Asia

Sanghui Park, Young Hyeh Ko

Progress in Hematology

Microenvironment of adult T-cell leukemia/lymphoma-associated nodal lesions

Koichi Ohshima, Daisuke Niino, Kennosuke Karube

Progress in Hematology

From empiric to mechanism-based therapy for peripheral T cell lymphoma

Andrew M. Intlekofer, Anas Younes

Original Article

Association of platelet ITGA2B and ITGB3 polymorphisms with ex vivo antiplatelet effect of ticagrelor in healthy Chinese male subjects

Mu-Peng Li, Yan Xiong, An Xu, Ji-Peng Zhou, Jie Tang, Zan-Ling Zhang, Hong-Hao Zhou, Wei Zhang, Xiao-Ping Chen

Original Article

Phase I study of cladribine, cytarabine, granulocyte colony stimulating factor (CLAG regimen) and midostaurin and all-trans retinoic acid in relapsed/refractory AML

Giridharan Ramsingh, Peter Westervelt, Ali McBride, Keith Stockerl-Goldstein, Ravi Vij, Mark Fiala, Geoffrey Uy, Amanda Cashen, John F. DiPersio, Camille N. Abboud

Original Article

Chromosome abnormalities in T-cell acute lymphoblastic leukemia in Korea

Joonhong Park, Myungshin Kim, Hae Kyung Lee, Yonggoo Kim, Kyungja Han, Jungok Son, Seok Lee, Nack-Gyun Chung, Bin Cho

Original Article

The impact of C-Myc gene-related aberrations in newly diagnosed myeloma with bortezomib/dexamethasone therapy

Naohiro Sekiguchi, Kaori Ootsubo, Miyuki Wagatsuma, Kiyoe Midorikawa, Akihisa Nagata, Satoshi Noto, Kazuaki Yamada, Naoki Takezako

Original Article

Prognostic significance of flow cytometric residual disease, dysregulated neutrophils/monocytes, and hematogones in adult acute myeloid leukemia in first remission

Sung-Chao Chu, Tso-Fu Wang, Yu-Chieh Su, Ruey-Ho Kao, Yi-Feng Wu, Dian-Kun Li, Szu-Chin Li, Chi-Cheng Li, Denise A. Wells, Michael R. Loken

Original Article

Expression levels of ASNS in mesenchymal stromal cells in childhood acute lymphoblastic leukemia

Helen Dimitriou, Christianna Choulaki, Chryssoula Perdikogianni, Eftichia Stiakaki, Maria Kalmanti

Original Article

A combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemia

Masahiro Ashizawa, Yu Akahoshi, Hirofumi Nakano, Tomotaka Ugai, Hidenori Wada, Ryoko Yamasaki, Yuko Ishihara, Koji Kawamura, Kana Sakamoto, Miki Sato, Kiriko Terasako, Shun-ichi Kimura, Misato Kikuchi, Hideki Nakasone, Shinichi Kako, Junya Kanda, Rie Yamazaki, Aki Tanihara, Junji Nishida, Yoshinobu Kanda

Original Article

Successful peripheral blood stem cell mobilization using pegfilgrastim in allogeneic stem cell transplantation

Chantiya Chanswangphuwana, Pawinee Kupatawintu, Panrudee Panjai, Paviga Tunsittipun, Tanin Intragumtornchai, Udomsak Bunworasate

Original Article

Chimerism status is correlated to acute graft-versus-host disease after allogeneic stem cell transplantation

Ying Jiang, Li-ping Wan, You-wen Qin, Xiao-rui Wang, Shi-ke Yan, Kuang-cheng Xie, Chun Wang

Original Article

Clinical significance of anti-endothelial cell antibody in allogeneic hematopoietic stem cell transplantation recipients with graft-versus-host disease

Jianfeng Yao, Axia Song, Wenbin Cao, Shulian Chen, Lukun Zhou, Shannan Cao, Peng Liu, Mei Wang, Yuanfu Xu, Aiming Pang, Sizhou Feng, Mingzhe Han

Original Article

Descriptive profile of β-thalassemia mutations in West Bengal population: a hospital-based study

Deboshree M. Bhattacharyya, Ashis Mukhopadhyay, Jayasri Basak

Erratum

Erratum to: A phase I/II study of ofatumumab (GSK1841157) in Japanese and Korean patients with relapsed or refractory B-cell chronic lymphocytic leukemia

Yoshiaki Ogawa, Michinori Ogura, Tatsuya Suzuki, Kiyoshi Ando, Toshiki Uchida, Yukari Shirasugi, Kensei Tobinai, Je Hwan Lee, Masazumi Kase, Koichi Katsura, Tomomitsu Hotta

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine